GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Cyclically Adjusted FCF per Share

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Cyclically Adjusted FCF per Share : ¥0.94 (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

China Resources Double-Crane Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥0.198. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.94 for the trailing ten years ended in Mar. 2024.

During the past 12 months, China Resources Double-Crane Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 4.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 8.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 11.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 17.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of China Resources Double-Crane Pharmaceutical Co was 35.70% per year. The lowest was 8.30% per year. And the median was 20.50% per year.

As of today (2024-05-15), China Resources Double-Crane Pharmaceutical Co's current stock price is ¥23.38. China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.94. China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 24.87.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of China Resources Double-Crane Pharmaceutical Co was 123.31. The lowest was 13.56. And the median was 31.66.


China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

China Resources Double-Crane Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 0.74 0.81 0.89 0.94

China Resources Double-Crane Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.92 0.95 0.94 0.94

Competitive Comparison of China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, China Resources Double-Crane Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.198/114.6694*114.6694
=0.198

Current CPI (Mar. 2024) = 114.6694.

China Resources Double-Crane Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.008 98.200 0.009
201409 0.190 98.900 0.220
201412 0.492 99.000 0.570
201503 0.007 99.900 0.008
201506 0.139 99.500 0.160
201509 0.151 100.500 0.172
201512 0.215 100.600 0.245
201603 0.137 102.200 0.154
201606 0.088 101.400 0.100
201609 0.234 102.400 0.262
201612 0.141 102.600 0.158
201703 0.264 103.200 0.293
201706 0.205 103.100 0.228
201709 0.180 104.100 0.198
201712 0.258 104.500 0.283
201803 0.329 105.300 0.358
201806 0.393 104.900 0.430
201809 0.347 106.600 0.373
201812 0.119 106.500 0.128
201903 0.376 107.700 0.400
201906 0.303 107.700 0.323
201909 0.344 109.800 0.359
201912 0.125 111.200 0.129
202003 0.305 112.300 0.311
202006 0.250 110.400 0.260
202009 0.237 111.700 0.243
202012 0.178 111.500 0.183
202103 0.251 112.662 0.255
202106 0.259 111.769 0.266
202109 0.179 112.215 0.183
202112 0.126 113.108 0.128
202203 0.029 114.335 0.029
202206 0.366 114.558 0.366
202209 0.074 115.339 0.074
202212 0.386 115.116 0.385
202303 0.028 115.116 0.028
202306 0.388 114.558 0.388
202309 0.232 115.339 0.231
202312 0.351 114.669 0.351
202403 0.198 114.669 0.198

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


China Resources Double-Crane Pharmaceutical Co  (SHSE:600062) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=23.38/0.94
=24.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of China Resources Double-Crane Pharmaceutical Co was 123.31. The lowest was 13.56. And the median was 31.66.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines